Tag Archives: Prostate Cancer

News

Former NIH director says that health care bill is an attack on patient choice

1 Comment

Story here at Hot Air. (Via Confederate Yankee via ECM)

Here’s the ex-NIH Director:

Dr. Bernardine Healy ran the National Institute of Health has a rather daunting resumé on health care issues.  She became the first woman to run the National Institute of Health in 1991, has served on two Presidential Council of Advisers on Science and Technology, and served as President of the Red Cross.

And here are her comments in US News:

The bill takes all sorts of choices out of patients’ and doctors’ hands. Even mammograms and prostate-specific antigen (PSA) tests would be similarly restricted by the government for millions of people, and they actually serve as better examples of what happens more broadly to personal medical decision making in the new system.

[…]As the pioneering prostate cancer surgeon Patrick Walsh of Johns Hopkins points out, a European randomized trial showed that PSAs saved lives. In the United States, there has been a 40 percent reduction in prostate cancer deaths since testing began in the early 1990s. Yet prostate screening arouses many of the same concerns as does breast cancer screening: too many follow-on studies, too many biopsies, and surgery on slow-growing tumors that may never have harmed the patient. The government task force claims that there’s insufficient evidence to make a recommendation for routine screening of men younger than 75 and is firmly against screening in men older than that. The American Urological Association’s position is the polar opposite: Baseline PSAs should be offered to men at age 40, and the frequency of subsequent testing should be determined by doctor and patient choice.

Ed Morrissey adds:

Prostate-specific antigen (PSA) tests help catch prostate cancer early. The American Urological Association wants men screened with the test beginning at age 40 to catch the problem at its earliest stages.

[…]The government board wants to move away from what it sees as excessive testing, claiming that it will reduce unnecessary stress and anxiety in patients. It’s no small coincidence that it will also save the government money — and in the case of PSAs, it will save money directly if Medicare refuses to pay for PSA tests until age 75, rather than retirement age.

Right now, the US leads the world in catching, treating, and curing prostate cancer. Britain, which has a single-payer system that rations care, has one of the lowest ratings in the world. That’s not a coincidence.

He who pays the piper calls the tune. If we want to keep patient choice, then we have to pay for our own care. If we allow the government to absorb our choices in the name of “fairness,” expect the USPSTF and other government panels to ration these tests and reduce our chances of surviving these cancers.

Previously, I wrote about a Stanford University professor’s survey of health care systems around the world, in which he compared American health care to single-payer systems, favored by those on the left. In Canada, there is a 184% increase in prostate cancer mortality rates, compared with American mortality rates for prostate cancer. That’s what we’re headed for if the public option passes.

News

In Oregon’s government-run health care system, lobbyists prioritize treatments

Leave a comment

See, this is one of the major problems with government-run health care. Whenver government runs anything, private businesses are going have to spend lots of money trying to influence government to favor their interests. That money would normally be spent pleasing customers, in the free market. But as soon as government gets involved in regulating anything, then lobbyists are hired.

Consider this video posted at Stop the ACLU about Oregon’s health care system. (H/T ECM)

Excerpt:

As it happens, each year politicians get together to decide what illnesses will get priority funding. Naturally, once the politicians (not doctors, but politicians) decide what “deserves” to be funded by Oregon’s government run healthcare system, the lobbyists flood in and begin to agitate for their own priorities.

The result is that often times serious illnesses end up pushed down this list as the political needs of lobbyists get pushed up to be funded first.

Ever wonder why socialized systems cover breast implants, sex changes, elective abortions, and in vitro fertilization?

Lobbying for illegal immigrants to be covered

Here’s some more lobbying going on right now about Obama’s plan.

ECM also send me this story from the Chicago Tribune, via Secondhand Smoke.

Immigration activists say it is “immoral” for hospitals and doctors, as well as a nation, to deny health care to the seriously ill, no matter their legal status. “Those of us with good health insurance just don’t have to live with because we can go get the medication,” said Jennifer Tolbert, a policy analyst at the non-profit Kaiser Family Foundation.

[…]”Concerns over the financial burden have led other hospitals to make…decisions denying treatment”, said Julie Contreras, an organizer in Chicago for the League of United Latin American Citizens.”These people, some of them are going to die,” Contreras said. “When a hospital denies treatment to any human being … this is flat-out immoral.”

Who is going to pay for this compassion? It isn’t free.

Anti-male discrimination

And don’t forget about anti-male discrimination in socialized systems, which I documented in a previous post.

Breast cancer mortality in Canada is 9 percent higher than in the United States, prostate cancer is 184 percent higher, and colon cancer among men is about 10 percent higher.

More than half of American men (54 percent) have had a prostatespecific antigen (PSA) test, compared to fewer than one in six Canadians (16 percent).

Why males vote Democrat is beyond me.

Commentary

MUST-READ: How does health care in the USA compare with other countries?

3 Comments

Story from the Hoover Institute at Stanford University, via ECM.

The article compares American health care to health care in other places like Canada, the UK and Europe.

I am particularly interested in prostate cancer rates, because that is a cancer that will necessarily be neglected by states that have single-payer systems. Why, you ask? Because only men get prostate cancer. And in a welfare state where leftist politicians are always catering to their special interest victim groups, men will definitely be discriminated against.

The full article. I almost never cite the full article, but this is a must read.

MEDICINE AND HEALTH:
Here’s a Second Opinion

By Scott W. Atlas

Ten reasons why America’s health care system is in better condition than you might suppose. By Scott W. Atlas.

Medical care in the United States is derided as miserable compared to health care systems in the rest of the developed world. Economists, government officials, insurers, and academics beat the drum for a far larger government role in health care. Much of the public assumes that their arguments are sound because the calls for change are so ubiquitous and the topic so complex. Before we turn to government as the solution, however, we should consider some unheralded facts about America’s health care system.

1. Americans have better survival rates than Europeans for common cancers. Breast cancer mortality is 52 percent higher in Germany than in the United States and 88 percent higher in the United Kingdom. Prostate cancer mortality is 604 percent higher in the United Kingdom and 457 percent higher in Norway. The mortality rate for colorectal cancer among British men and women is about 40 percent higher.

2. Americans have lower cancer mortality rates than Canadians. Breast cancer mortality in Canada is 9 percent higher than in the United States, prostate cancer is 184 percent higher, and colon cancer among men is about 10 percent higher.

3. Americans have better access to treatment for chronic diseases than patients in other developed countries. Some 56 percent of Americans who could benefit from statin drugs, which reduce cholesterol and protect against heart disease, are taking them. By comparison, of those patients who could benefit from these drugs, only 36 percent of the Dutch, 29 percent of the Swiss, 26 percent of Germans, 23 percent of Britons, and 17 percent of Italians receive them.

4. Americans have better access to preventive cancer screening than Canadians. Take the proportion of the appropriate-age population groups who have received recommended tests for breast, cervical, prostate, and colon cancer:

  • Nine out of ten middle-aged American women (89 percent) have had a mammogram, compared to fewer than three-fourths of Canadians (72 percent).
  • Nearly all American women (96 percent) have had a Pap smear, compared to fewer than 90 percent of Canadians.
  • More than half of American men (54 percent) have had a prostatespecific antigen (PSA) test, compared to fewer than one in six Canadians (16 percent).
  • Nearly one-third of Americans (30 percent) have had a colonoscopy, compared with fewer than one in twenty Canadians (5 percent).

5. Lower-income Americans are in better health than comparable Canadians. Twice as many American seniors with below-median incomes self-report “excellent” health (11.7 percent) compared to Canadian seniors (5.8 percent). Conversely, white, young Canadian adults with below-median incomes are 20 percent more likely than lower-income Americans to describe their health as “fair or poor.”

6. Americans spend less time waiting for care than patients in Canada and the United Kingdom. Canadian and British patients wait about twice as long—sometimes more than a year—to see a specialist, have elective surgery such as hip replacements, or get radiation treatment for cancer. All told, 827,429 people are waiting for some type of procedure in Canada. In Britain, nearly 1.8 million people are waiting for a hospital admission or outpatient treatment.

7. People in countries with more government control of health care are highly dissatisfied and believe reform is needed. More than 70 percent of German, Canadian, Australian, New Zealand, and British adults say their health system needs either “fundamental change” or “complete rebuilding.”

8. Americans are more satisfied with the care they receive than Canadians. When asked about their own health care instead of the “health care system,” more than half of Americans (51.3 percent) are very satisfied with their health care services, compared with only 41.5 percent of Canadians; a lower proportion of Americans are dissatisfied (6.8 percent) than Canadians (8.5 percent).

9. Americans have better access to important new technologies such as medical imaging than do patients in Canada or Britain. An overwhelming majority of leading American physicians identify computerized tomography (CT) and magnetic resonance imaging (MRI) as the most important medical innovations for improving patient care during the previous decade—even as economists and policy makers unfamiliar with actual medical practice decry these techniques as wasteful. The United States has thirty-four CT scanners per million Americans, compared to twelve in Canada and eight in Britain. The United States has almost twenty-seven MRI machines per million people compared to about six per million in Canada and Britain.

10. Americans are responsible for the vast majority of all health care innovations. The top five U.S. hospitals conduct more clinical trials than all the hospitals in any other developed country. Since the mid- 1970s, the Nobel Prize in medicine or physiology has gone to U.S. residents more often than recipients from all other countries combined. In only five of the past thirty-four years did a scientist living in the United States not win or share in the prize. Most important recent medical innovations were developed in the United States.

Despite serious challenges, such as escalating costs and care for the uninsured, the U.S. health care system compares favorably to those in other developed countries.

This essay appeared on the website of the National Center for Policy Analysis on March 24, 2009. An earlier version was published in the Washington Times.

Available from the Hoover Press is Power to the Patient: Selected Health Care Issues and Policy Solutions, edited by Scott W. Atlas. To order, call 800.935.2882 or visit www.hooverpress.org.

Scott W. Atlas is a senior fellow at the Hoover Institution and a professor of radiology and chief of neuroradiology at Stanford University Medical School.

Please forward this article to all of your friends! It’s important!